Showing 43,461 - 43,480 results of 111,445 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.33s Refine Results
  1. 43461
  2. 43462
  3. 43463

    Epitope mapping reveals a change in the CD8 T cell repertoire and in immunodominance. by Sama Adnan (693011)

    Published 2015
    “…<p>(A) Of the 37 CD8 T cell epitopes mapped for 6 SIVΔnef-vaccinated animals at week 5, only 14 epitopes were recognized at week 20. …”
  4. 43464

    Crystal Structures of Lanthanide(III) Complexes with Cyclen Derivative Bearing Three Acetate and One Methylphosphonate Pendants by Pavel Vojtíšek (2674720)

    Published 2005
    “…A series of lanthanide(III) complexes formulated as M[Ln(Hdo3ap)]·<i>x</i>H<sub>2</sub>O (M = Li or H and Ln = Tb, Dy, Er, Lu, and Y) with the monophosphonate analogue of H<sub>4</sub>dota, 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic-10-methylphosphonic acid (H<sub>5</sub>do3ap), was prepared in the solid state and studied using X-ray crystallography. …”
  5. 43465

    Peptides protect corneas from infection of <i>A. fumigatus</i> in vivo. by Ge Zhao (178636)

    Published 2012
    “…<p>(A–B) Treatment of corneas with peptide Pc-C or Pc-E around infection significantly decreased the disease scores at day 3 and 5 of post infection when compared with mock treated eyes (<i>P</i><0.05), but to less extent than Natamycin. …”
  6. 43466
  7. 43467
  8. 43468
  9. 43469
  10. 43470

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  11. 43471

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  12. 43472

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  13. 43473

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  14. 43474
  15. 43475
  16. 43476

    A proportion of CML patients do not respond during the first month of TKI therapy. by Mohamed El Missiry (3704836)

    Published 2017
    “…<p>A) The 1-month <i>BCR-ABL1</i> transcript value was divided by the <i>BCR-ABL1</i> transcript value at dg, and <i>poor responders</i> were identified as patients with fold change (FC) >1 (no decrease in the <i>BCR-ABL1</i> transcript level after 1 month). …”
  17. 43477

    A Transcript Cleavage Factor of <em>Mycobacterium tuberculosis</em> Important for Its Survival by Arnab China (137304)

    Published 2011
    “…Moreover, <em>Mtb</em>Gre failed to rescue <em>E. coli</em> RNAP stalled elongation complexes, indicating the importance of specific protein-protein interactions for transcript cleavage. Decrease in the level of <em>Mtb</em>Gre reduced the bacterial survival by several fold indicating its essential role in mycobacteria. …”
  18. 43478

    Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer by Kelly Coffey (129302)

    Published 2012
    “…<div><p>Tip60 (KAT5) is a histone acetyltransferase (HAT enzyme) involved in multiple cellular processes including transcriptional regulation, DNA damage repair and cell signalling. …”
  19. 43479
  20. 43480